Caspase-9 as a Potential Target for Pulmonary Fibrosis Treatment
A preclinical study suggests that blocking caspase-9, an enzyme involved in cell death, may be a potential treatment target for pulmonary fibrosis.
Researchers found that caspase-9 levels were elevated in lung tissue from individuals with pulmonary fibrosis and in a mouse model of the disease, particularly in diseased areas.
- Caspase-9 activity was blocked, resulting in reduced signs of cell death and lung fibrosis in the mouse model.
- Caspase-9 promotes lung fibrosis by triggering apoptosis and activating beta-catenin signaling.
Blocking caspase-9 may halt or reverse tissue scarring in pulmonary fibrosis.
Author's summary: Caspase-9 is a potential target for treating pulmonary fibrosis.
More News
- Trump Goes Full Dictator With Bonkers Threat to Use Air Force and Navy in U.S. Cities
- Tomago’s slow death exposes folly of ‘Made in Australia’ dream
- Trump Serenaded With Anthem YMCA as He Lands in South Korea
- Record Job Cuts at Amazon and UPS. AI and Reorganization Changing the Face of Logistics
- The UK needs regulation – but we can do it an awful lot better
- How Discrimination and Stress Impact the Mental Health of Young Sexual Minority Men